Skip to main content
. 2016 Oct 17;2:16078. doi: 10.1038/cddiscovery.2016.78

Figure 1.

Figure 1

(a) Annexin V-Cy3/6CFDA dual staining of HepG2 cells exposed to 1 and 10 μM arsenic trioxide with untreated control. Arsenic-treated cells of 1 μM demonstrate no significant changes as compared with control, whereas 10 μM arsenic-treated cells exhibit considerable number of apoptotic cells represented by Annexin V-Cy3/6CFDA dual-positive cells, which appears yellow-orange in the merged panel. (b) Typical apoptotic (dual-positive) and non-apoptotic (only 6CFDA positive) cell in higher magnification. (c) Apoptotic index calculated from comparisons of percent cell death revealed by MTT assay as well as percent apoptotic cells obtained from Annexin assay. Arrows represent the apoptotic cells.